Business Standard

Monday, December 23, 2024 | 04:17 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

USFDA completes pre-approval inspection at Biocon Malyasia

Image

Capital Market

Form 483 issued with 6 observations

Biocon announced that USFDA has completed a pre-approval inspection of its manufacturing facility in Malaysia and issued a Form 483 with 6 observations.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 21 2018 | 9:22 AM IST

Explore News